source
- Sanofi receives FDA clearance for Infilbray, first pill to treat neurological symptoms of Type 3 Gaucher diseaseSanofi received FDA clearance for Infilbray, a once-daily pill for Type 3 Gaucher disease in adults and children weighing at least 15 kilograms. The drug, inherited from Sanofi’s 2011 acquisition…
- Eli Lilly breaks ground on $3.5 billion Pennsylvania plant to produce obesity drugsEli Lilly has begun construction of a new manufacturing facility in the Lehigh Valley region of Pennsylvania. The $3.5 billion plant is slated to increase capacity for the company’s obesity drug po…